New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Athersys, Inc.(NASDAQ:ATHX), Novavax, Inc.(NASDAQ:NVAX ), AuRico Gold Inc(NYSE:AUQ),Peregrine Pharmaceuticals(NASDAQ:PPHM) Athersys, Inc.(NASDAQ:ATHX) reported loss -1.23% and closed at $4.00 with the total traded volume of 4.42M shares. Its market capitalization is $282.10M. The stock has a 52-week high price of 4.33 and its 52-week low was recorded at $1.14
Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
What ATHX Charts Are Signaling for Traders? Find Out Here
Novavax, Inc.(NASDAQ:NVAX ) unchanged and ended at $5.18.The total traded volume was 4.37M shares and market capitalization arrived at $1.08B. The stock has a 52-week high price of $5.45 and its 52-week low was recorded at $1.68, while during last trade its minimum price was $5.11 and it gained the highest price of $5.25.
Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines
Is NVAX Buy After The Recent Price Movement? Find Out Here
AuRico Gold Inc(NYSE:AUQ)’s reported the increase of 6.56% to close at $3.90 with the overall traded volume of 4.33M shares. Its market capitalization on last close reached to $965.52 million. Its intraday-low price was $3.70 and its hit its day's highest price at $3.94.
AuRico Gold Inc. is a Canada-based gold producer with mines and projects in North America. The Company and its subsidiaries are engaged in the mining, development, exploration, and acquisition of resource properties.
Should AUQ a Buy or Sell Now? Find Out Here
Peregrine Pharmaceuticals(NASDAQ:PPHM) gain 4.17% settle at $1.62. Its total traded volume during last trading session was 4.33M shares. The overall market worth of this company is about $260.53M. The 52 week range of the stock remained $1.11 - $2.43, while its day's lowest price was $1.57 and its hit its day's highest price at $1.66.
Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies.
What PPHM Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)